Skip to main content
Clinical Trials/NCT05353452
NCT05353452
Recruiting
Not Applicable

Collaborative Care for Anxiety and Depression in Posttraumatic Epilepsy

Wake Forest University Health Sciences1 site in 1 country40 target enrollmentApril 30, 2023

Overview

Phase
Not Applicable
Intervention
Neurology Based Collaborative Care
Conditions
Epilepsy, Post-Traumatic
Sponsor
Wake Forest University Health Sciences
Enrollment
40
Locations
1
Primary Endpoint
Emotional Subscale-Change in Quality of Life in Epilepsy-31(QOLIE-31)
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

The purpose of this research is to evaluate a 6 month change in quality of life in subjects who receive collaborative care calls compared to those subjects who receive usual neurology care. This is a 2-site trial comparing a 24 week neurology-based collaborative care program to usual neurology care among a total of 60 adults with post-traumatic epilepsy.

Detailed Description

The study will compare collaborative care versus usual care among N=60 adults with post-traumatic epilepsy and anxiety and/or depression symptoms in Veterans Administration (N=20) and civilian university (N=40) settings at the Salisbury VA and Atrium Health Neurology. This single-blind study will evaluate effectiveness and implementation of a remotely-delivered, 24-week team-delivered collaborative care intervention, with features adapted from VA Primary Care Mental Health Integration and Whole Health, as well as an existing Family Medicine Collaborative Care Program at AHWFB.

Registry
clinicaltrials.gov
Start Date
April 30, 2023
End Date
July 1, 2026
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures
  • Diagnosis of post-traumatic epilepsy, defined by the following:
  • Epilepsy diagnosis based on neurology clinician impression of diagnosis or electroencephalogram (EEG) findings (EEG findings: presence of interictal epileptiform discharges on EEG or ictal EEG recording of seizure definitively documenting epilepsy diagnosis)
  • History of at least mild traumatic brain injury based on the MIRECC (Mental Illness Research, Education, and Clinical Center) TBI (Traumatic Brain Injury) screening instrument or verified TBI history based on MIRECC research database
  • TBI pre-dated onset of epilepsy (NINDS post-traumatic epilepsy screening form)
  • Anxiety or depression symptoms--Generalized Anxiety Disorder scale (GAD-7) ≥8 or Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) \>13
  • Receiving clinical neurological care at one of the study sites

Exclusion Criteria

  • Active ongoing treatment by a psychiatrist without the potential to benefit from additional collaborative care for anxiety or depression in the judgement of the investigators
  • Active suicidal ideation
  • History of past suicide attempt
  • Unstable drug or alcohol abuse
  • Unstable or progressive comorbid medical condition
  • Current participation in another treatment or intervention study
  • Cognitive limitations precluding completion of anxiety and depression self-report instruments on paper, electronically, or by interview.

Arms & Interventions

Collaborative Care

Participants in this arm will receive 24 weeks of neurology based collaborative care.

Intervention: Neurology Based Collaborative Care

Standard of Care (SOC)

Participants in this arm will receive provider-recommended clinic visits, prescriptions, testing, and referrals.

Intervention: SOC Neurological care

Outcomes

Primary Outcomes

Emotional Subscale-Change in Quality of Life in Epilepsy-31(QOLIE-31)

Time Frame: Baseline through Month 6

This is a clinically meaningful patient reported outcome measure that was demonstrated to improve in collaborative care efficacy trials in distinct patient groups (including with various different types of medical illness) Score ranges from 0-100 with higher score indicating better quality of life

Secondary Outcomes

  • Change in Beck Depression Inventory-II (BDI-II) score(From baseline through Month 6)
  • Subject Adherence to Intervention(Week 12)
  • Change in Epilepsy specific QOLIE-31 score(Baseline through Month 6)
  • Change in Beck Anxiety Index (BAI) score(From baseline through Month 6)

Study Sites (1)

Loading locations...

Similar Trials